澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RHYTHM BIOSCIENCES LTD

0.210

-0.030-12.50%

成交量：137.56萬

成交額：30.28萬

市值：6,847.44萬

市盈率：-15.00

高：0.240

開：0.240

低：0.210

收：0.240

52周最高：0.280

52周最低：0.047

股本：3.26億

流通股本：1.88億

量比：0.66

換手率：0.73%

股息：- -

股息率：- -

每股收益(TTM):-0.014

每股收益(LYR):-0.014

淨資產收益率：-501.54%

總資產收益率：-107.16%

市淨率：103.77

市盈率(LYR):-14.77

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Rhythm Biosciences與Quansys Biosciences達成多年商業供應協議，負責Colostat試劑盒生產

Rhythm Biosciences與AGRF達成戰略合作加速Genetype服務商業化進程

Datma與RHYTHM BIOSCIENCES LTD宣佈合作，應用聯邦真實世界數據推動基因檢測開發

RHYTHM BIOSCIENCES LTD - 與皇家薩里國民保健基金信託的南方中心研究團隊達成合作

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RHY.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.21,"timestamp":1770959520000,"preClose":0.24,"halted":0,"volume":1375589,"delay":0,"changeRate":-0.125,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.014,"marketStatus":"休市中","change":-0.03,"latestTime":"02-13 16:12:00 AEDT","open":0.24,"high":0.24,"low":0.21,"amount":302808,"amplitude":0.125,"askPrice":0.215,"askSize":12179,"bidPrice":0.21,"bidSize":144000,"shortable":3,"etf":0,"ttmEps":-0.014,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1771196400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.24,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0.657997227142,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-107.16%","roe":"-501.54%","lyrEps":-0.014222,"volumeRatio":0.657997227142,"shares":326068419,"dividePrice":0,"high":0.24,"amplitude":0.125,"preClose":0.24,"low":0.21,"week52Low":0.047,"pbRate":"103.77","psRate":"21.45","week52High":0.28,"institutionHeld":0,"latestPrice":0.21,"committee":0.844038,"eps":-0.014,"divideRate":0,"volume":1375589,"delay":0,"ttmEps":-0.014,"open":0.24,"prevYearClose":0.135,"prevWeekClose":0.245,"prevMonthClose":0.145,"prevQuarterClose":0.135,"fiveDayClose":0.245,"twentyDayClose":0.16,"sixtyDayClose":0.083,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1149288581","title":"Rhythm Biosciences與Quansys Biosciences達成多年商業供應協議，負責Colostat試劑盒生產","url":"https://stock-news.laohu8.com/highlight/detail?id=1149288581","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149288581?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 05:46","pubTimestamp":1770068794,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences Ltd (ASX: RHY) 已与Quansys Biosciences签署一项多年期商业供应协议，旨在推进其结直肠癌筛查产品Colostat试剂盒的规模化生产。该协议的签署标志着公司核心产品商业化进程迈出关键一步，为后续市场供应奠定了稳定的产能基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"1147877827","title":"Rhythm Biosciences與AGRF達成戰略合作 加速Genetype服務商業化進程","url":"https://stock-news.laohu8.com/highlight/detail?id=1147877827","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147877827?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 09:51","pubTimestamp":1769651517,"startTime":"0","endTime":"0","summary":"1月29日——RHYTHM BIOSCIENCES LTD宣布与AGRF建立战略联盟关系。此次合作将推动Genetype服务的商业化规模扩张，加速该技术平台的量产应用进程。\n通过整合双方在生物技术领域的专业优势，这一战略伙伴关系有望为精准医疗市场带来更高效的基因分型解决方案。合作将聚焦于技术转化与市场落地，构建从研发到商业化的完整产业链。\n此次联盟标志着Rhythm Biosciences在推进分子诊断技术规模化应用方面迈出关键一步，为未来全球市场拓展奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"1160035181","title":"Datma與RHYTHM BIOSCIENCES LTD宣佈合作，應用聯邦真實世界數據推動基因檢測開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1160035181","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160035181?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 21:08","pubTimestamp":1766408925,"startTime":"0","endTime":"0","summary":"Datma与RHYTHM BIOSCIENCES LTD宣布合作，应用联邦真实世界数据推动基因检测开发","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"1138402806","title":"RHYTHM BIOSCIENCES LTD - 與皇家薩里國民保健基金信託的南方中心研究團隊達成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1138402806","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138402806?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 05:58","pubTimestamp":1765317523,"startTime":"0","endTime":"0","summary":"RHYTHM BIOSCIENCES LTD - 与皇家萨里国民保健基金信托的南方中心研究团队达成合作","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RHY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}